Real-World Reductions in Oral Corticosteroid Use in the USA Following Mepolizumab Therapy for Severe Asthma

BACKGROUND: Patients with severe asthma often require oral corticosteroid (OCS) treatment. Clinical trials have demonstrated that mepolizumab can reduce OCS dependence, but real-world data are limited. OBJECTIVE: To evaluate the impact of mepolizumab on OCS use, asthma exacerbations, and asthma exac...

Descripción completa

Detalles Bibliográficos
Autores principales: Silver, Jared, Bogart, Michael, Packnett, Elizabeth, Wu, Juan, McMorrow, Donna, Hahn, Beth
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7751313/
https://www.ncbi.nlm.nih.gov/pubmed/33364788
http://dx.doi.org/10.2147/JAA.S275944

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7751313/
https://www.ncbi.nlm.nih.gov/pubmed/33364788
http://dx.doi.org/10.2147/JAA.S275944

Ejemplares similares